The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 27, 2024

Filed:

Dec. 11, 2019
Applicant:

Takeda Pharmaceutical Company Limited, Osaka, JP;

Inventors:

Yuhei Miyanohana, Kanagawa, JP;

Yuichi Kajita, Kanagawa, JP;

Tatsuki Koike, Kanagawa, JP;

Yasutaka Hoashi, Kanagawa, JP;

Yasushi Hattori, Kanagawa, JP;

Norihito Tokunaga, Kanagawa, JP;

Tsuneo Oda, Kanagawa, JP;

Tohru Miyazaki, Kanagawa, JP;

Dilhumar Uyghur, Kanagawa, JP;

Yoshiteru Ito, Kanagawa, JP;

Kohei Takeuchi, Kanagawa, JP;

Keisuke Imamura, Kanagawa, JP;

Takahiro Sugimoto, Kanagawa, JP;

Koichiro Fukuda, Kanagawa, JP;

Yasuhisa Kohara, Kanagawa, JP;

Rei Okamoto, Kanagawa, JP;

Taiichi Ohra, Kanagawa, JP;

Naoki Miyamoto, Kanagawa, JP;

Jun Chiba, Kanagawa, JP;

Yoshito Terao, Kanagawa, JP;

Masanori Kawasaki, Kanagawa, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 455/02 (2006.01); A61P 25/26 (2006.01); C07D 217/24 (2006.01); C07D 237/32 (2006.01); C07D 239/90 (2006.01); C07D 401/06 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 417/06 (2006.01); C07D 471/04 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 455/02 (2013.01); A61P 25/26 (2018.01); C07D 217/24 (2013.01); C07D 237/32 (2013.01); C07D 239/90 (2013.01); C07D 401/06 (2013.01); C07D 401/10 (2013.01); C07D 403/10 (2013.01); C07D 417/06 (2013.01); C07D 471/04 (2013.01); C07D 498/04 (2013.01); C07B 2200/05 (2013.01);
Abstract

The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.


Find Patent Forward Citations

Loading…